查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生命科學工具的全球市場的評估:各類型，各技術，各產品，各終端用戶，各地區，機會，預測(2016年～2030年)
市場調查報告書
商品編碼
1297161

生命科學工具的全球市場的評估:各類型，各技術，各產品，各終端用戶，各地區，機會，預測(2016年～2030年)

Life Science Tools in Healthcare Market Assessment, By Type, By Technology, By Product, By End-user, By Region, Opportunities and Forecast, 2016-2030F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 126 Pages | 商品交期: 3-5個工作天內

價格

全球生命科學工具的市場規模將從2022年的1,512億8,000萬美元2030年達到3,156億6,000萬美元，在2023年～2030年的預測期間內預計將以年複合成長率9.63％的速度成長。生物製藥公司增加投資以創造先進的治療方法，對新藥物和治療方法的需求不斷增長，以及流式細胞儀、光譜儀、顯微鏡、色譜柱和核酸處理器等儀器的快速採用。癌症等慢性病的流行等因素、糖尿病和甲狀腺疾病正在推動市場。

本報告提供全球生命科學工具市場相關調查分析，提供市場規模與預測，市場動態，主要企業的形勢及預測等資訊。

目錄

第1章 調查手法

第2章 計劃的範圍和定義

第3章 全球生命科學工具市場上COVID-19的影響

第4章 摘要整理

第5章 全球生命科學工具市場預測(2016年～2030年)

  • 市場規模與預測
    • 金額
    • 數量
  • 各類型
    • 器具
    • 消耗品
    • 服務
  • 各技術
    • 基因學
    • 蛋白質體學
    • 細胞生物學技術
    • 實驗用品
    • 其他
  • 各產品
    • 細胞培養系統·3D細胞培養
    • 液體層析法
    • 質譜分析法
    • 流式細胞技術
    • 基因複製·基因工程
    • 顯微鏡檢驗
    • 次世代定序
    • PCR·qPCR
    • 核酸的製作
    • 核酸微陣列
    • 桑格測序
    • 轉染設備·遺傳基因輸送(給藥)技術
    • 核磁共振(NMR)
    • 其他
  • 各終端用戶
    • 醫療
    • 政府·學術機構
    • 生物醫藥品企業
    • 產業用途
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 南美
    • 亞太地區
    • 中東·非洲
  • 市場佔有率:各企業(2022年)

第6章 全球生命科學工具市場預測:各地區(2016年～2030年)

  • 北美
    • 各類型
    • 各技術
    • 各產品
    • 各終端用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳洲
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第7章 市場製圖(2022年)

  • 各類型
  • 各技術
  • 各終端用戶
  • 各產品
  • 各地區

第8章 宏觀環境和產業結構

  • 供需的分析
  • 進出口的分析 - 數量和金額
  • 支援/價值鏈分析
  • PESTEL分析
  • 波特的五力分析

第9章 市場動態

  • 成長促進因素
  • 阻礙成長的要素(課題，阻礙因素)

第10章 法律規範和革新

  • 臨床試驗
  • 專利的形勢
  • 法規當局的認證
  • 革新/最新技術

第11章 主要企業形勢

  • 前五大市場領導者公司的競爭矩陣
  • 前五大市場領導者公司的市場收益分析(2022年)
  • 合併和收購/合資企業(如果符合)
  • SWOT分析(5大市場參與企業)
  • 如果專利分析(相符合)

第12章 價格分析

第13章 案例研究

第14章 主要企業預測

  • Becton, Dickinson, and Company
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • GE Healthcare
  • Bruker Corporation
  • Qiagen NV
  • Danaher Corporation
  • Abbott Laboratories Inc.
  • Shimadzu Corporation
  • Hitachi, Ltd.
  • Oxford Instruments plc
  • Zeiss International

第15章 策略性推薦事項

第16章 關於本公司·免責聲明

Product Code: MX10157

Global Life Science Tools market size was valued at USD 151.28 billion in 2022 which is expected to reach USD 315.66 billion in 2030 with a CAGR of 9.63% for the forecast period between 2023 and 2030. The rapid development of life sciences tools and technologies such as gene sequencing, mass spectroscopy, chromatography, nuclear magnetic resonance (NMR), and other varied goods is contributing to innovation.

Additionally, the market is being driven by factors such as increasing investments by biopharmaceutical companies for the creation of advanced therapies, increasing need for novel medicines and treatments, rapid adoption of instruments such as flow cytometers, spectrometers, microscopes, chromatography columns, nucleic acid processing equipment and increasing prevalence of chronic diseases such as cancer, diabetes, thyroid disorders and many others.

The development of molecular diagnostic techniques such as digital droplet PCR, next-generation sequencing (NGS), and genome-wide sequencing has led to the introduction of DNA testing in clinical settings. For instance, Illumina, a global leader in DNA sequencing, and Genoscreen, a genomics company announced their partnership in October 2022 to speed up ending tuberculosis globally. This collaboration aims to enhance resources and skills in nations greatly affected by tuberculosis, such as India, to improve the efficiency of identifying and fighting against multidrug-resistant TB.

Increasing Demand for Biopharmaceuticals

The growing need for biologics, which often utilize recombinant DNA technology, is expected to fuel the expansion of the life science tools market. Biopharmaceuticals offer advantages such as increased efficacy, reduced adverse effects, minimized risk of drug interactions and improved patient outcomes. To meet the increasing demand and enhance the production of biological treatments, the life science industry is currently focusing on advanced analytical models such as predictive analytics. These cutting-edge innovations are being facilitated by significant technological improvements such as laboratory upgrades, strategic advancements, and operational optimizations. The demand for biopharmaceutical products has increased due to their enhanced safety, effectiveness, and ability to cure previously untreatable medical conditions.

Rapid Technological Advancements

Technological advancements have led to the growing utilization of various tools in the field, such as next sequencers, PCR (Polymerase Chain Reaction) and qPCR (quantitative polymerase chain reaction) machines, flow cytometers, spectrometers, microscopes, chromatography columns, nucleic acid processing equipment, and cell biology instruments. These advancements have had a significant impact on the integration of DNA assays in clinical settings, specifically in molecular diagnostic techniques like digital droplet PCR, NGS, and genome-wide sequencing. These methods have improved accuracy, timeframe, and reproducibility. To effectively harness the therapeutic potential of circulating nucleic acids, it is crucial to have an efficient extraction process.

Becton , Dickinson and Company (BD), a prominent global medical technology company, and Labcorp, a premier life sciences company, announced a strategic collaboration in August 2022. The collaboration aims to establish a framework for the development, production, marketing, and commercialization of companion diagnostics (CDx) based on flow cytometry. These CDx solutions are designed to complement the administration of potentially life-altering therapies for cancer and similar diseases.

Healthcare Sector is Experiencing Rapid Growth

The healthcare sector emerged as the leading contributor to the market value in 2022 and is expected to exhibit significant growth throughout the forecast period. This segment encompasses clinics, hospitals, community centers, diagnostic laboratories, and physician offices. The increasing adoption of proteomic and genomic workflows in hospitals for the diagnosis and treatment of various clinical abnormalities is predicted to drive market growth. The healthcare sector's expansion is primarily attributed to the extensive utilization and demand for tissue diagnostic solutions in hospitals. Clinicians are increasingly opting for tissue-based diagnostic tests over conventional methods due to their quick turnaround time. The integration of genomic sequencing in hospitals and clinical settings is predicted to improve patient care and reduce healthcare costs. This development is expected to drive the rapid growth of the healthcare sector. Furthermore, advancements in tools and equipment have significantly enhanced the accuracy of complex medical procedures in hospitals. The precision and reliability of medical diagnostic outcomes largely rely on the laboratory tools utilized for analysis, which positively impacts the expansion of the market.

For Instance, in January 2023, QIAGEN entered into an exclusive strategic agreement with Helix, a population genomics company based in California. According to the recently disclosed agreement, QIAGEN will have exclusive rights to market and handle contracts for Helix's companion diagnostic services within the United States. This collaboration will utilize the Helix Laboratory Platform, which has received the pioneering de novo class II authorization from the U.S. Food & Drug Administration for a comprehensive exome sequencing platform.

Growth of Cell and Gene Therapies is Propelling Market Growth

The utilization of genomic technologies on a global scale is on the rise, leading to advancements in diagnostic tests and procedures for various diseases and driving the growth of the market. A recent example is the commercial launch of a new molecular polymerase chain reaction (PCR) assay for the monkeypox virus by Becton, Dickinson, and Company (BD) and CerTest Biotec in September 2022, targeting both the United States and global markets. It is important to note that this PCR assay is currently intended for research purposes only. With the introduction of such innovative products, the market is expected to experience robust growth throughout the projected period. A comprehensive understanding of cell biology has emerged as an asset in laboratory workflows, creating new opportunities for market expansion. Furthermore, scientists in the life science field are keen to adopt cutting-edge instruments, which is anticipated to further strengthen this segment. Companies such as Cytiva, BioTek Instruments, Horizon Discovery, and Seahorse Bioscience are introducing instruments related to cell analysis, cell biology and imaging. The demand for tools and equipment is being propelled by the rising research and development activities conducted by prominent industrial companies.

A notable example is the strategic partnership between Haihe and EdiGene Laboratory, announced in January 2022, aimed at developing platform technologies and stem regenerative cell treatments. This collaboration focuses on exploring advanced biomarkers to enhance quality control in stem cell production.

Impact of COVID-19

The COVID-19 pandemic has had a significant impact on the life science tools industry and their respective supply chains worldwide. This disruption can be attributed to several factors, including the scarcity of raw materials and labor, as well as interruptions in the transportation of these materials across regions. As a result, there has been a shortage of critical medical supplies in different parts of the world, including molecular and immunoassay kits, digital solutions, life-support machines, and drugs. The COVID-19 pandemic had spurred a competitive race among manufacturers to create rapid diagnostics for the detection of SARS-CoV-2 virus, resulting in remarkable advancements and breakthroughs in terms of innovative solutions. These tests utilize various methods such as PCR for detecting the SARS-CoV-2 nucleic material, nucleic acid hybridization-related techniques, or serological and immunological assays for detecting antibodies produced in response to the virus.

For instance, in December 2021, Siemens Healthineers obtained emergency use authorization from the FDA for its 'Clinitest', a rapid COVID -19 antigen self-test, that can be self-administered by individuals aged 14 and above.

Key Players Landscape and Outlook

The market is characterized by strong competition as numerous players offer similar products. These players are consistently expanding their product portfolios and introducing new platforms through extensive research and development efforts to maintain their market position. Moreover, major companies are undertaking strategic initiatives such as collaborations, mergers and acquisitions, and new product launches to drive market growth and intensify competition. For example, in February 2022, Agilent Technologies, Inc. formed a partnership with Biosciences, Inc. to integrate the AVITI System with SureSelect target enrichment panels, aiming to provide customers with improved access to genomic tools. This initiative was anticipated to create fresh growth opportunities for the company.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Global Life Science Tools Market

4. Executive Summary

5. Global Life Science Tools Market Outlook, 2016-2030F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Type
    • 5.2.1. Instruments
    • 5.2.2. Consumables
    • 5.2.3. Services
  • 5.3. By Technology
    • 5.3.1. Genomics
    • 5.3.2. Proteomics
    • 5.3.3. Cell Biology Technology
    • 5.3.4. Lab Supplies
    • 5.3.5. Others
  • 5.4. By Product
    • 5.4.1. Cell Culture Systems & 3D Cell Culture
    • 5.4.2. Liquid Chromatography
    • 5.4.3. Mass Spectrometry
    • 5.4.4. Flow Cytometry
    • 5.4.5. Cloning & Genome Engineering
    • 5.4.6. Microscopy
    • 5.4.7. Next Generation Sequencing
    • 5.4.8. PCR & qPCR
    • 5.4.9. Nucleic Acid Preparation
    • 5.4.10. Nucleic Acid Microarray
    • 5.4.11. Sanger Sequencing
    • 5.4.12. Transfection Devices & Gene Delivery Technologies
    • 5.4.13. Nuclear Magnetic Resonance (NMR)
    • 5.4.14. Others
  • 5.5. By End-user
    • 5.5.1. Healthcare
      • 5.5.1.1. Hospitals
      • 5.5.1.2. Clinics
      • 5.5.1.3. Research Laboratories
      • 5.5.1.4. Diagnostic Laboratories
      • 5.5.1.5. Physician Office
      • 5.5.1.6. Community Centres
    • 5.5.2. Government & Academic Institutions
    • 5.5.3. Biopharmaceutical Company
    • 5.5.4. Industrial Applications
    • 5.5.5. Others
  • 5.6. By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. South America
    • 5.6.4. Asia-Pacific
    • 5.6.5. Middle East and Africa
  • 5.7. By Company Market Share (%), 2022

6. Global Life Science Tools Market Outlook, By Region, 2016-2030F

  • 6.1. North America*
    • 6.1.1. By Type
      • 6.1.1.1. Instruments
      • 6.1.1.2. Consumables
      • 6.1.1.3. Services
    • 6.1.2. By Technology
      • 6.1.2.1. Genomics
      • 6.1.2.2. Proteomics
      • 6.1.2.3. Cell Biology Technology
      • 6.1.2.4. Lab Supplies
      • 6.1.2.5. Others
    • 6.1.3. By Product
      • 6.1.3.1. Cell Culture Systems & 3D Cell Culture
      • 6.1.3.2. Liquid Chromatography
      • 6.1.3.3. Mass Spectrometry
      • 6.1.3.4. Flow Cytometry
      • 6.1.3.5. Cloning & Genome Engineering
      • 6.1.3.6. Microscopy
      • 6.1.3.7. Next Generation Sequencing
      • 6.1.3.8. PCR & qPCR
      • 6.1.3.9. Nucleic Acid Preparation
      • 6.1.3.10. Nucleic Acid Microarray
      • 6.1.3.11. Sanger Sequencing
      • 6.1.3.12. Transfection Devices & Gene Delivery Technologies
      • 6.1.3.13. Nuclear Magnetic Resonance (NMR)
      • 6.1.3.14. Others
    • 6.1.4. By End-user
      • 6.1.4.1. Healthcare
      • 6.1.4.1.1. Hospitals
      • 6.1.4.1.2. Clinics
      • 6.1.4.1.3. Research Laboratories
      • 6.1.4.1.4. Diagnostic Laboratories
      • 6.1.4.1.5. Physician Office
      • 6.1.4.1.6. Community Centres
      • 6.1.4.2. Government & Academic Institutions
      • 6.1.4.3. Biopharmaceutical Company
      • 6.1.4.4. Industrial Applications
      • 6.1.4.5. Others
    • 6.1.5. United States*
      • 6.1.5.1. By Type
      • 6.1.5.1.1. Instruments
      • 6.1.5.1.2. Consumables
      • 6.1.5.1.3. Services
      • 6.1.5.2. By Technology
      • 6.1.5.2.1. Genomics
      • 6.1.5.2.2. Proteomics
      • 6.1.5.2.3. Cell Biology Technology
      • 6.1.5.2.4. Lab Supplies
      • 6.1.5.2.5. Others
      • 6.1.5.3. By Product
      • 6.1.5.3.1. Cell Culture Systems & 3D Cell Culture
      • 6.1.5.3.2. Liquid Chromatography
      • 6.1.5.3.3. Mass Spectrometry
      • 6.1.5.3.4. Flow Cytometry
      • 6.1.5.3.5. Cloning & Genome Engineering
      • 6.1.5.3.6. Microscopy
      • 6.1.5.3.7. Next Generation Sequencing
      • 6.1.5.3.8. PCR & qPCR
      • 6.1.5.3.9. Nucleic Acid Preparation
      • 6.1.5.3.10. Nucleic Acid Microarray
      • 6.1.5.3.11. Sanger Sequencing
      • 6.1.5.3.12. Transfection Devices & Gene Delivery Technologies
      • 6.1.5.3.13. Nuclear Magnetic Resonance (NMR)
      • 6.1.5.3.14. Others
      • 6.1.5.4. By End-user
      • 6.1.5.4.1. Healthcare
      • 6.1.5.4.1.1. Hospitals
      • 6.1.5.4.1.2. Clinics
      • 6.1.5.4.1.3. Research Laboratories
      • 6.1.5.4.1.4. Diagnostic Laboratories
      • 6.1.5.4.1.5. Physician Office
      • 6.1.5.4.1.6. Community Centres
      • 6.1.5.4.2. Government & Academic Institutions
      • 6.1.5.4.3. Biopharmaceutical Company
      • 6.1.5.4.4. Industrial Applications
      • 6.1.5.4.5. Others
    • 6.1.6. Canada
    • 6.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 6.2. Europe
    • 6.2.1. Germany
    • 6.2.2. France
    • 6.2.3. Italy
    • 6.2.4. United Kingdom
    • 6.2.5. Russia
    • 6.2.6. Netherlands
    • 6.2.7. Spain
    • 6.2.8. Turkey
    • 6.2.9. Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Mexico
    • 6.3.3. Argentina
  • 6.4. Asia-Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2022

  • 7.1. By Type
  • 7.2. By Technology
  • 7.3. By End-user
  • 7.4. By Product
  • 7.5. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis - Volume and Value
  • 8.3. Supply/Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges, Restraints)

10. Regulatory Framework and Innovation

  • 10.1. Clinical Trials
  • 10.2. Patent Landscape
  • 10.3. Regulatory Approvals
  • 10.4. Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Becton, Dickinson, and Company
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Agilent Technologies Inc.
  • 14.3. Illumina Inc.
  • 14.4. Thermo Fisher Scientific Inc.
  • 14.5. F. Hoffmann-La Roche Ltd
  • 14.6. Bio-Rad Laboratories Inc.
  • 14.7. Merck KGaA
  • 14.8. GE Healthcare
  • 14.9. Bruker Corporation
  • 14.10. Qiagen NV
  • 14.11. Danaher Corporation
  • 14.12. Abbott Laboratories Inc.
  • 14.13. Shimadzu Corporation
  • 14.14. Hitachi, Ltd.
  • 14.15. Oxford Instruments plc
  • 14.16. Zeiss International

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15. Strategic Recommendations

16. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 2. Global Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 3. Global Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 4. Global Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 5. Global Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 6. Global Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 7. Global Life Science Tools Market Share, By Region, In USD Billion, 2016-2030F
  • Figure 8. North America Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 9. North America Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 10. North America Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 11. North America Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 12. North America Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 13. North America Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 14. North America Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 15. United States Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 16. United States Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 17. United States Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 18. United States Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 19. United States Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 20. United States Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 21. Canada Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 22. Canada Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 23. Canada Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 24. Canada Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 25. Canada Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 26. Canada Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 27. Mexico Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 28. Mexico Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 29. Mexico Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 30. Mexico Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 31. Mexico Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 32. Mexico Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 33. Europe Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 34. Europe Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 35. Europe Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 36. Europe Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 37. Europe Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 38. Europe Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 39. Europe Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 40. Germany Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 41. Germany Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 42. Germany Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 43. Germany Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 44. Germany Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 45. Germany Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 46. France Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 47. France Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 48. France Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 49. France Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 50. France Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 51. France Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 52. Italy Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 53. Italy Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 54. Italy Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 55. Italy Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 56. Italy Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 57. Italy Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 58. United Kingdom Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 59. United Kingdom Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 60. United Kingdom Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 61. United Kingdom Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 62. United Kingdom Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 63. United Kingdom Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 64. Russia Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 65. Russia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 66. Russia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 67. Russia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 68. Russia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 69. Russia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 70. Netherlands Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 71. Netherlands Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 72. Netherlands Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 73. Netherlands Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 74. Netherlands Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 75. Netherlands Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 76. Spain Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 77. Spain Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 78. Spain Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 79. Spain Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 80. Spain Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 81. Spain Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 82. Turkey Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 83. Turkey Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 84. Turkey Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 85. Turkey Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 86. Turkey Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 87. Turkey Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 88. Poland Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 89. Poland Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 90. Poland Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 91. Poland Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 92. Poland Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 93. Poland Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 94. South America Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 95. South America Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 96. South America Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 97. South America Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 98. South America Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 99. South America Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 100. South America Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 101. Brazil Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 102. Brazil Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 103. Brazil Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 104. Brazil Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 105. Brazil Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 106. Brazil Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 107. Argentina Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 108. Argentina Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 109. Argentina Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 110. Argentina Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 111. Argentina Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 112. Argentina Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 113. Asia-Pacific Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 114. Asia-Pacific Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 115. Asia-Pacific Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 116. Asia-Pacific Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 117. Asia-Pacific Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 118. Asia-Pacific Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 119. Asia-Pacific Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 120. India Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 121. India Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 122. India Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 123. India Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 124. India Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 125. India Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 126. China Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 127. China Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 128. China Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 129. China Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 130. China Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 131. China Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 132. Japan Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 133. Japan Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 134. Japan Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 135. Japan Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 136. Japan Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 137. Japan Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 138. Australia Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 139. Australia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 140. Australia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 141. Australia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 142. Australia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 143. Australia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 144. Vietnam Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 145. Vietnam Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 146. Vietnam Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 147. Vietnam Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 148. Vietnam Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 149. Vietnam Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 150. South Korea Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 151. South Korea Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 152. South Korea Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 153. South Korea Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 154. South Korea Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 155. South Korea Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 156. Indonesia Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 157. Indonesia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 158. Indonesia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 159. Indonesia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 160. Indonesia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 161. Indonesia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 162. Philippines Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 163. Philippines Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 164. Philippines Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 165. Philippines Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 166. Philippines Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 167. Philippines Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 168. Middle East & Africa Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 169. Middle East & Africa Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 170. Middle East & Africa Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 171. Middle East & Africa Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 172. Middle East & Africa Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 173. Middle East & Africa Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 174. Middle East & Africa Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 175. Saudi Arabia Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 176. Saudi Arabia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 177. Saudi Arabia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 178. Saudi Arabia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 179. Saudi Arabia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 180. Saudi Arabia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 181. UAE Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 182. UAE Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 183. UAE Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 184. UAE Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 185. UAE Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 186. UAE Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 187. South Africa Life Science Tools Market, By Value, In USD Billion, 2016-2030F
  • Figure 188. South Africa Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F
  • Figure 189. South Africa Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 190. South Africa Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F
  • Figure 191. South Africa Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F
  • Figure 192. South Africa Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F
  • Figure 193. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 195. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022